We confirm that metabolic pathways related to nucleotide biosynthesis, such as the NME1 signature, are related to highly proliferative tumors and have a role in HCC progression [29], although this role could be non-HCC-specific but common to other cancer types. Here, NME1 is linked to hepatocellular carcinoma.